172 related articles for article (PubMed ID: 18071871)
21. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
Herr HW; Toner GC; Geller NL; Bosl GJ
Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
[TBL] [Abstract][Full Text] [Related]
22. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
[TBL] [Abstract][Full Text] [Related]
23. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Sheinfeld J
Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
[TBL] [Abstract][Full Text] [Related]
24. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
25. [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Yanada S; Ito H; Tomita M; Wada T; Hatano T; Kishimoto K; Egawa S
Hinyokika Kiyo; 2008 Jan; 54(1):43-6. PubMed ID: 18260360
[TBL] [Abstract][Full Text] [Related]
26. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
Beck SD; Foster RS; Bihrle R; Ulbright T; Koch MO; Wahle GR; Einhorn LH; Donohue JP
J Urol; 2002 Oct; 168(4 Pt 1):1402-4. PubMed ID: 12352402
[TBL] [Abstract][Full Text] [Related]
27. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
28. Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report.
Iida K; Naiki T; Kawai N; Ando R; Etani T; Tozawa K; Kohri K
BMC Res Notes; 2014 Dec; 7():865. PubMed ID: 25444462
[TBL] [Abstract][Full Text] [Related]
29. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
Powles T
Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
[TBL] [Abstract][Full Text] [Related]
30. Surgery for treatment of metastatic testicular cancer.
Zargar H; Aning JJ; So AI
ANZ J Surg; 2015 Mar; 85(3):189-90. PubMed ID: 24171695
[No Abstract] [Full Text] [Related]
31. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
32. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
33. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
[TBL] [Abstract][Full Text] [Related]
34. Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.
Pedrosa JA; Masterson TA; Rice KR; Bihrle R; Beck SD; Foster RS
J Urol; 2014 Jun; 191(6):1777-82. PubMed ID: 24518787
[TBL] [Abstract][Full Text] [Related]
35. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
36. Radical retroperitoneal node dissection after chemotherapy for testicular tumours.
Williams SN; Jenkins BJ; Baithun SI; Oliver RT; Blandy JP
Br J Urol; 1989 Jun; 63(6):641-3. PubMed ID: 2546643
[TBL] [Abstract][Full Text] [Related]
37. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
38. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Gilligan T
J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
[TBL] [Abstract][Full Text] [Related]
39. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.
Fox EP; Weathers TD; Williams SD; Loehrer PJ; Ulbright TM; Donohue JP; Einhorn LH
J Clin Oncol; 1993 Jul; 11(7):1294-9. PubMed ID: 8391067
[TBL] [Abstract][Full Text] [Related]
40. Late relapse of testicular cancer 21 years after first complete remission: a case report.
Kohei N; Kinoshita H; Kamoto T; Terai A; Kakehi Y; Ogawa O
Hinyokika Kiyo; 2008 Jan; 54(1):39-42. PubMed ID: 18260359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]